This Target Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Needham analyst Gil Blum downgraded the rating for Sarepta Therapeutics, Inc. SRPT from Hold to Underperform. Sarepta Therapeutics shares closed at $14.07 on Friday. See how other analysts view this stock.
Barclays analyst Seth Sigman downgraded Target Corporation TGT from Equal-Weight to Underweight and announced a $91 price target. Target shares closed at $103.46 on Friday. See how other analysts view this stock.
Leerink Swann analyst Mani Foroohar downgraded Sarepta Therapeutics, Inc. SRPT from Outperform to Market Perform and cut the price target from $45 to $10. Sarepta Therapeutics shares closed at $14.07 on Friday. See how other analysts view this stock.
Truist Securities analyst Patrick Scholes downgraded Royal Caribbean Cruises Ltd. RCL from Buy to Hold but raised the price target from $275 to $337. Royal Caribbean shares closed at $350.10 on Friday. See how other analysts view this stock.
TD Cowen analyst Ryan Langston downgraded Centene Corporation CNC from Buy to Hold and cut the price target from $73 to $33. Centene shares closed at $27.95 on Friday. See how other analysts view this stock.